Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Trametinib (GSK1120212)

InhA, Func 871700-17-3
Produktnummer ABIN3222045
  • Applikation
    Inhibition Assay (InhA), Functional Studies (Func)
    Verwendungszweck
    Trametinib is an orally bioavailable inhibitor of mitogen-activated protein kinase kinase (MEK MAPK/ERK kinase) with potential antineoplastic activity. Trametinib specifically binds to and inhibits MEK 1 and 2, resulting in an inhibition of growth factor-mediated cell signaling and cellular proliferation in various cancers. MEK 1 and 2, dual specificity threonine/tyrosine kinases often upregulated in various cancer cell types, play a key role in the activation of the RAS/RAF/MEK/ERK signaling pathway that regulates cell growth.
    Produktmerkmale
    Target: MEK inhibitor
    Receptor: MEK1, MEK2
    Aufreinigung
    All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
    Reinheit
    98 %
    Formel
    C26H23FIN5O4
    Löslichkeit
    Soluble in DMSO
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Solid
    Lagerung
    -20 °C
    Informationen zur Lagerung
    For the majority of compounds, they could be dissolved in DMSO or other organic solvent.
    Their stock solution can be stored at -20°C for up to 3 months and aliquoted for sampling convenience.
    Several freeze/thaw cycles should not damage the activity of our small molecule products.
    However, in many instances the aqueous solutions of some compounds need to be made fresh and cannot be stored. For these compounds, their solution should be prepared just before use and stored no longer than 24 hours.
    Haltbarkeit
    24 months
  • Hintergrund
    MAPK Signaling
    Molekulargewicht
    615.39 g/mol
    CAS-Nummer
    871700-17-3
Sie sind hier:
Kundenservice